BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/27/2025 7:53:53 AM | Browse: 10 | Download: 44
 |
Received |
|
2025-08-04 09:19 |
|
Peer-Review Started |
|
2025-08-04 09:19 |
|
First Decision by Editorial Office Director |
|
2025-08-15 09:05 |
|
Return for Revision |
|
2025-08-15 09:05 |
|
Revised |
|
2025-08-18 14:21 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-09-28 02:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-09-28 06:55 |
|
Articles in Press |
|
2025-09-28 06:55 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-10-31 13:06 |
|
Publish the Manuscript Online |
|
2025-11-27 07:53 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Tumor necrosis factor alpha-induced protein 3: Biomarker discovery and therapeutic advancement in primary biliary cholangitis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Khaled Mohamed Mohamed Koriem |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Khaled Mohamed Mohamed Koriem, Professor, Department of Medical Physiology, Medical Research and Clinical Studies Institute, National Research Centre, 33 El-Buhouth Street, Dokki, P.O. Box, Giza 12622, Egypt. kkoriem@yahoo.com |
| Key Words |
Tumor necrosis factor alpha-induced protein 3; Ursodeoxycholic acid; Fatigue; Biomarkers prediction; Primary biliary cholangitis treatment |
| Core Tip |
The novel work by Zang et al examined tumor necrosis factor alpha-induced protein 3 (TNFAIP3), a new biomarker, to predict ursodeoxycholic acid (UDCA) efficiency in primary biliary cholangitis (PBC). PBC patients' TNFAIP3 expression was significantly higher than that in healthy controls. The response to UDCA in PBC was substantially impacted by both TNFAIP3 and fatigue. TNFAIP3 may be a suitable biomarker or therapeutic target for PBC because its expression was also connected with splenomegaly, alkaline phosphatase, albumin, total bilirubin, and age. |
| Publish Date |
2025-11-27 07:53 |
| Citation |
Koriem KMM. Tumor necrosis factor alpha-induced protein 3: Biomarker discovery and therapeutic advancement in primary biliary cholangitis. World J Hepatol 2025; 17(11): 112679 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i11/112679.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i11.112679 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
